Jonas Lindblom, MSc, PhD

Jonas is Senior Consultant with 2 years of experience at Parexel. He is leading and participating in various market access related activities, typically reimbursement applications in the Nordic countries. Jonas has a special focus on areas with atypical scientific evidence, e.g. orphan disease and gene- and cell therapies.

Jonas has experience from HTA projects in many different therapeutic areas, although specialised in neuroscience (psychiatry and neurology) and in areas with limited scientific evidence, such as orphan diseases.

Work experience

Prior to joining Parexel, he has 12+ years of experience of health technology assessment from two government agencies in Sweden, most recently the Dental and pharmaceutical benefits agency where he spent 6+ years as a Senior Medical Investigator. Since joining Parexel, Jonas has led and/or participated in numerous market access projects in the Nordics, including several orphan drug and gene- and cell therapy reimbursement applications.

Education

Jonas has a MSc in pharmaceutical biosciences, and a PhD in pharmacology from Uppsala university. Jonas is an associate professor in functional pharmacology, Department of neuroscience, Uppsala university.